COVID‐19 Vaccine Response in People with Multiple Sclerosis

OBJECTIVE: The purpose of this study was to investigate the effect of disease modifying therapies on immune response to severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) vaccines in people with multiple sclerosis (MS). METHODS: Four hundred seventy‐three people with MS provided one or mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tallantyre, Emma C., Vickaryous, Nicola, Anderson, Valerie, Asardag, Aliye Nazli, Baker, David, Bestwick, Jonathan, Bramhall, Kath, Chance, Randy, Evangelou, Nikos, George, Katila, Giovannoni, Gavin, Godkin, Andrew, Grant, Leanne, Harding, Katharine E., Hibbert, Aimee, Ingram, Gillian, Jones, Meleri, Kang, Angray S., Loveless, Samantha, Moat, Stuart J., Robertson, Neil P., Schmierer, Klaus, Scurr, Martin J., Shah, Sita Navin, Simmons, Jessica, Upcott, Matthew, Willis, Mark, Jolles, Stephen, Dobson, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652739/
https://www.ncbi.nlm.nih.gov/pubmed/34687063
http://dx.doi.org/10.1002/ana.26251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652739/
https://www.ncbi.nlm.nih.gov/pubmed/34687063
http://dx.doi.org/10.1002/ana.26251

Ejemplares similares